Epithelial-mesenchymal transition orchestrates tumor microenvironment: Current perceptions and challenges

The biology <b>,</b> function <b>,</b> and biomedical applications of exosomes

Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770 · see citing works

The basics of epithelial-mesenchymal transition

Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · see citing works

Epithelial-Mesenchymal Transitions in Development and Disease

Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · see citing works

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368 · see citing works

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,679 · see citing works

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin

Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323 · see citing works

Understanding the tumor immune microenvironment (TIME) for effective therapy

Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145 · see citing works

EMT: 2016

Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492 · see citing works

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059 · see citing works

New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876 · see citing works

The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

Cano, A., Pérez‐Moreno, M., Rodrigo, I., Locascio, A., Blanco, M. J., Barrio, M. G. D., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,672 · see citing works

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797 · see citing works

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545 · see citing works

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539 · see citing works

The ErbB signaling network: receptor heterodimerization in development and cancer

Olayioye, M. A., Neve, R. M., Lane, H. A., & Hynes, N. E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,438 · see citing works

Concepts of extracellular matrix remodelling in tumour progression and metastasis

Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296 · see citing works

Guidelines and definitions for research on epithelial-mesenchymal transition

Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., et al. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0237-9 · Cited by 2,226 · see citing works

EMT and Dissemination Precede Pancreatic Tumor Formation

Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136 · see citing works

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,952 · see citing works

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis

Yu, Q., & Stamenkovic, I. (2000) · Genes &amp; Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · see citing works

Phenotype molding of stromal cells in the lung tumor microenvironment

Lambrechts, D., Wauters, E., Boeckx, B., Aibar, S., Nittner, D., Burton, O., Bassez, A., Decaluwé, H., Pircher, A., Van den Eynde, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0096-5 · Cited by 1,648 · see citing works

Pathways of Antigen Processing

Blum, J. S., Wearsch, P. A., & Cresswell, P. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095910 · Cited by 1,561 · see citing works

Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice

Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., Upadhyay, P., Uyeminami, D. L., Pommier, A., Küttner, V., et al. (2018) · Science · doi:10.1126/science.aao4227 · Cited by 1,476 · see citing works

Extracellular Vesicles: Unique Intercellular Delivery Vehicles

Maas, S. L. N., Breakefield, X. O., & Weaver, A. M. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.003 · Cited by 1,419 · see citing works

Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231 · see citing works

CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness

Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230 · see citing works

Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition

Salmon, H., Idoyaga, J., Rahman, A. H., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M. N., Agudo, J., Tung, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.012 · Cited by 1,187 · see citing works

Role of extracellular matrix assembly in interstitial transport in solid tumors.

Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165 · see citing works

Targeting TGF-β signal transduction for fibrosis and cancer therapy

Peng, D., Fu, M., Wang, M., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01569-x · Cited by 1,106 · see citing works

Role of Extracellular Matrix in Development and Cancer Progression

Walker, C., Mojares, E., & Hernández, A. E. D. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103028 · Cited by 1,103 · see citing works

Lactate: A Metabolic Key Player in Cancer

Hirschhaeuser, F., Sattler, U. G. A., & Mueller‐Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,093 · see citing works

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,065 · see citing works

Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs

Jabłońska-Trypuć, A., Matejczyk, M., & Rosochacki, S. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1161620 · Cited by 1,042 · see citing works

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S. K., Yang, J., Hartwell, K. A., Önder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004900107 · Cited by 1,041 · see citing works

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer

Krebs, A. M., Mitschke, J., Losada, M. L., Schmalhofer, O., Boerries, M., Busch, H. S., Böttcher, M., Mougiakakos, D., Reichardt, W., Bronsert, P., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3513 · Cited by 979 · see citing works

Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1

Ocaña, O. H., Córcoles, R. C., Fabra, À., Moreno‐Bueno, G., Acloque, H., Vega, S., Barrallo‐Gimeno, A., Cano, A., & Nieto, M. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.012 · Cited by 973 · see citing works

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y., Byers, L. A., Zhang, X., Yi, X., Dwyer, D. W., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 972 · see citing works

Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells

Nieto, M. A. (2013) · Science · doi:10.1126/science.1234850 · Cited by 962 · see citing works

Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell

Kagan, H. M., & Li, W. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10413 · Cited by 954 · see citing works

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

Kudo‐Saito, C., Shirako, H., Takeuchi, T., & Kawakami, Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.023 · Cited by 872 · see citing works

We need to talk about the Warburg effect

DeBerardinis, R. J., & Chandel, N. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0172-2 · Cited by 864 · see citing works

TGF-β Activation and Function in Immunity

Travis, M. A., & Sheppard, D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120257 · Cited by 856 · see citing works

Targeting immunosuppressive adenosine in cancer

Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.86 · Cited by 852 · see citing works

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

Bartoschek, M., Oskolkov, N., Bocci, M., Lövrot, J., Larsson, C., Sommarin, M., Madsen, C. D., Lindgren, D., Pekar, G., Karlsson, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07582-3 · Cited by 826 · see citing works

Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W. ‐., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.022 · Cited by 806 · see citing works

A guide to antigen processing and presentation

Pishesha, N., Harmand, T. J., & Ploegh, H. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00707-2 · Cited by 805 · see citing works

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

Teijeira, Á., Garasa, S., Gato, M., Alfaro, C., Miguéliz, I., Cirella, A., de Andrea, C., Ochoa, M. C., Otano, I., Etxeberría, I., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.001 · Cited by 799 · see citing works

Interleukins in cancer: from biology to therapy

Briukhovetska, D., Dörr, J., Endres, S., Libby, P., Dinarello, C. A., & Kobold, S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00363-z · Cited by 791 · see citing works

A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis

Su, S., Liu, Q., Chen, J., Chen, J., Chen, F., He, C., Huang, D., Wu, W., Lin, L., Huang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.021 · Cited by 775 · see citing works

Dynamic EMT: a multi‐tool for tumor progression

Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 770 · see citing works

Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1

Noë, V., Fingleton, B., Jacobs, K., Crawford, H. C., Vermeulen, S. J. T., Steelant, W. F. A., Bruyneel, E. A., Matrisian, L. M., & Mareel, M. M. K. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.111 · Cited by 697 · see citing works

Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and InfectionPreprint

Sanjabi, S., Oh, S. A., & Li, M. O. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022236 · Cited by 626 · see citing works

Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment

Fu, C., & Jiang, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03059 · Cited by 602 · see citing works

The rationale for targeting the LOX family in cancer

Barker, H. E., Cox, T. R., & Erler, J. T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3319 · Cited by 592 · see citing works

Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer

Topper, M. J., Vaz, M., Chiappinelli, K. B., DeStefano Shields, C. E., Niknafs, N., Yen, R.-W. C., Wenzel, A., Hicks, J., Ballew, M., Stone, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.022 · Cited by 537 · see citing works

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition

Mak, M. P., Tong, P., Diao, L., Cardnell, R. J., Gibbons, D. L., William, W. N., Skoulidis, F., Parra, E. R., Rodriguez‐Canales, J., Wistuba, I. I., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0876 · Cited by 526 · see citing works

Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics

Yamaguchi, H., Hsu, J.-M., Yang, W., & Hung, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00601-9 · Cited by 507 · see citing works

The UCSC Genome Browser database: 2016 update

Speir, M. L., Zweig, A. S., Rosenbloom, K. R., Raney, B. J., Paten, B., Nejad, P., Lee, B. T., Learned, K., Karolchik, D., Hinrichs, A. S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1275 · Cited by 451 · see citing works

Material stiffness influences the polarization state, function and migration mode of macrophages

Sridharan, R., Cavanagh, B., Cameron, A. R., Kelly, D. J., & O'Brien, F. J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.048 · Cited by 450 · see citing works

Collagen density regulates the activity of tumor-infiltrating T cells

Kuczek, D. E., Larsen, A. M. H., Thorseth, M., Carretta, M., Kalviša, A., Siersbæk, M. S., Simões, A. M. C., Roslind, A., Engelholm, L. H., Noeßner, E., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0556-6 · Cited by 441 · see citing works

Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion

Peng, D. H., Rodriguez, B. L., Diao, L., Chen, L., Wang, J., Byers, L. A., Wei, Y., Chapman, H. A., Yamauchi, M., Behrens, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18298-8 · Cited by 441 · see citing works

A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing

Cella, M., Döhring, C., Samaridis, J., Dessing, M., Brockhaus, M., Lanzavecchia, A., & Colonna, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1743 · Cited by 430 · see citing works

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

Viganó, S., Alatzoglou, D., Irving, M. B., Ménétrier‐Caux, C., Caux, C., Romero, P. J., & Coukos, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00925 · Cited by 422 · see citing works

New insights into the role of <scp>EMT</scp> in tumor immune escape

Terry, S., Savagner, P., Ortiz‐Cuaran, S., Mahjoubi, L., Saintigny, P., Thiery, J., & Chouaib, S. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12093 · Cited by 414 · see citing works

Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion

Sun, X., Wu, B., Chiang, H.-C., Deng, H., Zhang, X., Xiong, W., Liu, J., Rozeboom, A. M., Harris, B. T., Blommaert, E., et al. (2021) · Nature · doi:10.1038/s41586-021-04057-2 · Cited by 407 · see citing works

CD39/CD73/A2AR pathway and cancer immunotherapy

Xia, C., Yin, S., To, K. K. W., & Fu, L. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01733-x · Cited by 406 · see citing works

Mechanisms of RNA loading into exosomes

Janas, T., Janas, M. M., Sapoń, K., & Janas, T. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.036 · Cited by 397 · see citing works

Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas

Dongre, A., Rashidian, M., Reinhardt, F., Bagnato, A., Keckesova, Z., Ploegh, H. L., & Weinberg, R. A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3292 · Cited by 395 · see citing works

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Saatci, Ö., Kaymak, A., Raza, U., Ersan, P. G., Akbulut, Ö., Banister, C. E., Sikirzhytski, V., Tokat, Ü. M., Aykut, G., Ansari, S. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16199-4 · Cited by 373 · see citing works

Collective cell migration requires suppression of actomyosin at cell–cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6

Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S. I., Williamson, P., Harrington, K. J., Leitinger, B., & Sahai, E. A. (2010) · Nature Cell Biology · doi:10.1038/ncb2133 · Cited by 363 · see citing works

Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation

Mendler, A. N., Hu, B., Prinz, P. U., Kreutz, M. P., Gottfried, E., & Noeßner, E. (2011) · International Journal of Cancer · doi:10.1002/ijc.26410 · Cited by 320 · see citing works

Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment

Tharp, K. M., Kersten, K., Maller, O., Timblin, G. A., Stashko, C., Canale, F. P., Menjivar, R. E., Hayward, M.-K., Berestjuk, I., ten Hoeve, J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00775-4 · Cited by 304 · see citing works

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation

Taki, M., Abiko, K., Baba, T., Hamanishi, J., Yamaguchi, K. D., Murakami, R., Yamanoi, K., Horikawa, N., Hosoe, Y., Nakamura, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03966-7 · Cited by 296 · see citing works

SNAIL Regulates Interleukin-8 Expression, Stem Cell–Like Activity, and Tumorigenicity of Human Colorectal Carcinoma Cells

Hwang, W., Yang, M., Tsai, M., Lan, H., Su, S., Chang, S., Teng, H., Yang, S., Lan, Y., Chiou, S., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.008 · Cited by 295 · see citing works

B7-H3/CD276: An Emerging Cancer Immunotherapy

Zhou, W.-T., & Jin, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701006 · Cited by 295 · see citing works

Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy

Miller, B. W., Morton, J. P., Pinese, M., Saturno, G., Jamieson, N. B., McGhee, E. J., Timpson, P., Leach, J. D. G., McGarry, L., Shanks, E. J., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404827 · Cited by 289 · see citing works

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells

Alsuliman, A., Çolak, D., Al‐Harazi, O., Fitwi, H., Tulbah, A. M., Al‐Tweigeri, T., Al-Alwan, M. M., & Ghebeh, H. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0421-2 · Cited by 288 · see citing works

Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells

Miyoshi, A., Kitajima, Y., Sumi, K., Sato, K., Hagiwara, A., Koga, Y., & Miyazaki, K. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601685 · Cited by 283 · see citing works

Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers

Krześlak, A., Wójcik‐Krowiranda, K., Forma, E., Jóźwiak, P., Romanowicz, H., Bieńkiewicz, A., & Bryś, M. (2012) · Pathology & Oncology Research · doi:10.1007/s12253-012-9500-5 · Cited by 280 · see citing works

DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer

Luo, N., Nixon, M. J., Gonzalez-Ericsson, P. I., Sanchez, V., Opalenik, S. R., Li, H., Zahnow, C. A., Nickels, M. L., Liu, F., Tantawy, M. N., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02630-w · Cited by 275 · see citing works

Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity

Skrypek, N., Goossens, S., Smedt, E. D., Vandamme, N., & Berx, G. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.08.004 · Cited by 270 · see citing works

Vimentin regulates activation of the NLRP3 inflammasome

dos Santos, G., Rogel, M. R., Baker, M. A., Troken, J. R., Urich, D., Morales‐Nebreda, L., Sennello, J. A., Kutuzov, M. A., Sitikov, A. S., Davis, J. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7574 · Cited by 269 · see citing works

Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs

Lamouille, S., Subramanyam, D., Blelloch, R. H., & Derynck, R. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.01.008 · Cited by 257 · see citing works

New frontiers in immune checkpoint B7-H3 (CD276) research and drug development

Getu, A. A., Tigabu, A., Zhou, M., Lu, J., Fodstad, Ø., & Tan, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01751-9 · Cited by 255 · see citing works

The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200

Noman, M. Z., Janji, B., Abdou, A., Hasmim, M., Terry, S., Tan, T. Z., Mami-Chouaib, F., Thiery, J. P., & Chouaib, S. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1263412 · Cited by 253 · see citing works

Immune Modulatory Properties of Collagen in Cancer

Rømer, A. M. A., Thorseth, M., & Madsen, D. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791453 · Cited by 231 · see citing works

Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer

Bhome, R., Vecchio, F. D., Lee, G.-H., Bullock, M. D., Primrose, J. M., Sayan, E., & Mirnezami, A. H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.002 · Cited by 224 · see citing works

Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

Huang, X., Zhang, P., Wei, C., Peng, R., Lu, J., Gao, C., Cai, J.-B., Yang, X., Fan, J., Ke, A., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01213-6 · Cited by 223 · see citing works

Dihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition

Shaul, Y. D., Freinkman, E., Comb, W. C., Cantor, J. R., Tam, W. L., Thiru, P., Kim, D., Kanarek, N., Pacold, M. E., Chen, W. W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.032 · Cited by 217 · see citing works

LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint

Zhao, L., Liu, Y., Zhang, J., Liu, Y., & Qi, Q. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1886-5 · Cited by 217 · see citing works

Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma

Miyoshi, A., Kitajima, Y., Kido, S., Shimonishi, T., Matsuyama, S., Kitahara, K., & Miyazaki, K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602266 · Cited by 216 · see citing works

Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis

Yang, C., Dou, R., Chen, W., Liu, K., Shi, D., Zhang, C., Liu, Q., Wang, S., & Xiong, B. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.006 · Cited by 215 · see citing works

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy

Zhao, B., Li, H., Xia, Y., Wang, Y., Wang, Y., Shi, Y., Xing, H., Qu, T., Wang, Y., & Ma, W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01364-7 · Cited by 213 · see citing works

ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis

Peng, D. H., Ungewiss, C., Tong, P., Byers, L. A., Wang, J., Canales, J. R., Villalobos, P. A., Uraoka, N., Mino, B., Behrens, C., et al. (2016) · Oncogene · doi:10.1038/onc.2016.358 · Cited by 211 · see citing works

Matrix Metalloproteinases and Cancer - Roles in Threat and Therapy

Yadav, L., Puri, N., Rastogi, V., Satpute, P., Ahmad, R., & Kaur, G. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.3.1085 · Cited by 209 · see citing works

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome

Tripathi, S. C., Peters, H. L., Taguchi, A., Katayama, H., Wang, H., Momin, A. A., Jolly, M. K., Çeliktaş, M., Rodriguez‐Canales, J., Liu, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521812113 · Cited by 203 · see citing works

KLRG1—more than a marker for T cell senescence

Henson, S. M., & Akbar, A. N. (2009) · AGE · doi:10.1007/s11357-009-9100-9 · Cited by 191 · see citing works

Acetylation of Snail Modulates the Cytokinome of Cancer Cells to Enhance the Recruitment of Macrophages

Hsu, D. S., Wang, H.-J., Tai, S., Chou, C.-H., Hsieh, C.-H., Chiu, P.-H., Chen, N., & Yang, M. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.002 · Cited by 191 · see citing works

Twist1 Induces CCL2 and Recruits Macrophages to Promote Angiogenesis

Low-Marchelli, J. M., Ardi, V. C., Vizcarra, E. A., van Rooijen, N., Quigley, J. P., & Yang, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0653 · Cited by 191 · see citing works

Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer

Jiang, H., Wei, H., Wang, H., Wang, Z., Li, J., Ou, Y., Xiao, X., Wang, W., Chang, A., Sun, W., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04632-z · Cited by 190 · see citing works

Snail-overexpressing Cancer Cells Promote M2-Like Polarization of Tumor-Associated Macrophages by Delivering MiR-21-Abundant Exosomes

Hsieh, C.-H., Tai, S., & Yang, M. (2018) · Neoplasia · doi:10.1016/j.neo.2018.06.004 · Cited by 186 · see citing works

Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target

Jonckheere, S., Adams, J., Groote, D. D., Campbell, K., Berx, G., & Goossens, S. (2021) · Cells Tissues Organs · doi:10.1159/000512218 · Cited by 173 · see citing works

The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis

Yu, M., Yongzhi, H., Chen, S., Luo, X., Lin, Y., Zhou, Y., Jin, H., Hou, B., Deng, Y., Tu, L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17445 · Cited by 167 · see citing works

Erratum: Targeting immunosuppressive adenosine in cancer

Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.110 · Cited by 167 · see citing works

PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung

Kim, S., Koh, J., Kim, M., Kwon, D., Go, H., Kim, Y. A., Jeon, Y. K., & Chung, D. H. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.07.007 · Cited by 166 · see citing works

ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM

Zhou, Y., Lin, F., Wan, T. Y., Chen, A., Wang, H., Jiang, B., Zhao, W., Liao, S., Wang, S., Li, G., et al. (2021) · Theranostics · doi:10.7150/thno.56490 · Cited by 163 · see citing works

Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity

Xia, H., Wang, W., Crespo, J., Kryczek, I., Li, W., Wei, S., Bian, Z., Maj, T., He, M., Liu, J. R., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan4631 · Cited by 155 · see citing works

GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer

Masin, M., Vázquez, J., Rossi, S., Groeneveld, S., Samson, N., Schwalie, P. C., Deplancke, B., Frawley, L. E., Gouttenoire, J., Moradpour, D., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-11 · Cited by 154 · see citing works

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma

Ock, C.-Y., Kim, S., Keam, B., Kim, M., Kim, T. M., Kim, J.-H., Jeon, Y. K., Lee, J., Kwon, S. K., Hah, J. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7431 · Cited by 146 · see citing works

PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation

Qiu, X. Y., Hu, D. X., Chen, W., Chen, R. Q., Shi, Q., Li, C. Y., Li, Y. J., Xiong, X., Liu, D., Pan, F., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.002 · Cited by 144 · see citing works

Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment

Chen, X.-J., Deng, Y.-R., Wang, Z., Wei, W.-F., Zhou, C.-F., Zhang, Y., Yan, R.-M., Liang, L.-J., Zhong, M., Li, L., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1748-1 · Cited by 139 · see citing works

Milk Fat Globule EGF-8 Promotes Melanoma Progression through Coordinated Akt and Twist Signaling in the Tumor Microenvironment

Jinushi, M., Nakazaki, Y., Carrasco, D. R., Draganov, D., Souders, N. C., Johnson, M., Mihm, M. C., & Dranoff, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2147 · Cited by 125 · see citing works

HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer

Fukumoto, T., Fatkhutdinov, N., Zundell, J. A., Tcyganov, E. N., Nacarelli, T., Karakashev, S. V., Wu, S., Liu, Q., Gabrilovich, D. I., & Zhang, R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1302 · Cited by 124 · see citing works

Programmed death‐ligand 1 expression at tumor invasive front is associated with epithelial‐mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma

Tsutsumi, S., Saeki, H., Nakashima, Y., Ito, S., Oki, E., Morita, M., Oda, Y., Okano, S., & Maehara, Y. (2017) · Cancer Science · doi:10.1111/cas.13237 · Cited by 119 · see citing works

Matrix stiffness regulates macrophage polarisation via the <scp>Piezo1‐YAP</scp> signalling axis

Mei, F., Guo, Y., Wang, Y., Zhou, Y., Heng, B. C., Xie, M., Huang, X., Zhang, S., Ding, S., Liu, F., et al. (2024) · Cell Proliferation · doi:10.1111/cpr.13640 · Cited by 118 · cited 1× · see citing works

PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma

Wang, Y., Wang, H., Zhao, Q., Xia, Y., Hu, X., & Guo, J. (2015) · Medical Oncology · doi:10.1007/s12032-015-0655-2 · Cited by 114 · see citing works

PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer

Chen, L., Xiong, Y., Li, J., Zheng, X. W., Zhou, Q., Turner, A., Wu, C., Lu, B., & Jiang, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480000 · Cited by 110 · see citing works

Immune Promotion of Epithelial-mesenchymal Transition and Generation of Breast Cancer Stem Cells

Reiman, J. M., Knutson, K. L., & Radisky, D. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4041 · Cited by 107 · see citing works

CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy

Turcotte, M., Allard, D., Mittal, D., Barèche, Y., Buisseret, L., José, V., Pommey, S., Delisle, V., Loi, S., Joensuu, H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0707 · Cited by 106 · see citing works

Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion

Sun, C., Lan, P., Han, Q., Huang, M., Zhang, Z., Xu, G., Song, J., Wang, J., Wei, H., Zhang, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03584-3 · Cited by 102 · see citing works

Intratumoral Induction of CD103 Triggers Tumor-Specific CTL Function and CCR5-Dependent T-Cell Retention

Franciszkiewicz, K., Floc’h, A. L., Jalil, A., Vigant, F., Robert, T., Vergnon, I., Mackiewicz, A. A., Benihoud, K., Validire, P., Chouaı̈b, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3571 · Cited by 96 · see citing works

ZEB1 transcription factor promotes immune escape in melanoma

Plaschka, M., Benboubker, V., Grimont, M., Berthet, J., Tonon, L., Lopez, J., Bouar, M. L., Balme, B., Tondeur, G., de la Fouchardière, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003484 · Cited by 96 · see citing works

Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases

Rachman-Tzemah, C., Zaffryar‐Eilot, S., Grossman, M., Ribero, D., Timaner, M., Mäki, J. M., Myllyharju, J., Bertolini, F., Hershkovitz, D., Sagi, I., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.005 · Cited by 96 · see citing works

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy

B, J. R. V. B., Huijbers, E. J. M., van Loon, K., Blanas, A., Akbari, P., Roos, A., Wong, T. J., Denisov, S. S., Hackeng, T. M., Jiménez, C. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30063-7 · Cited by 96 · see citing works

B7-H1 Overexpression Regulates Epithelial–Mesenchymal Transition and Accelerates Carcinogenesis in Skin

Cao, Y., Zhang, L., Kamimura, Y., Ritprajak, P., Hashiguchi, M., Hirose, S., & Azuma, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2217 · Cited by 94 · see citing works

Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance

Cheng, H.-Y., Hsieh, C.-H., Lin, P., Chen, Y.-T., Hsu, D. S., Tai, S., Chu, P., & Yang, M. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004832 · Cited by 93 · see citing works

aPKC‐ι/P‐Sp1/Snail signaling induces epithelial–mesenchymal transition and immunosuppression in cholangiocarcinoma

Qian, Y., Yao, W., Yang, T., Yang, Y., Liu, Y., Shen, Q., Zhang, J., Qi, W., & Wang, J. (2017) · Hepatology · doi:10.1002/hep.29296 · Cited by 93 · see citing works

MiR-199a-5p Loss Up-Regulated DDR1 Aggravated Colorectal Cancer by Activating Epithelial-to-Mesenchymal Transition Related Signaling

Hu, Y., Liu, J., Jiang, B., Chen, J., Fu, Z., Bai, F., Jiang, J., & Tang, Z. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3136-0 · Cited by 91 · see citing works

Interaction of KLRG1 with E‐cadherin: New functional and structural insights

Rosshart, S. P., Hofmann, M., Schweier, O., Pfaff, A.-K., Yoshimoto, K., Takeuchi, T., Molnár, E., Schamel, W. W. A., & Pircher, H. (2008) · European Journal of Immunology · doi:10.1002/eji.200838690 · Cited by 89 · see citing works

CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype

Zeng, W., Xiong, L., Wu, W., Li, S., Liu, J., Yang, L., Lao, L., Huang, P., Zhang, M., Chen, H., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02540-2 · Cited by 88 · see citing works

Characterization of mouse CD4 T cell subsets defined by expression of KLRG1

Beyersdorf, N., Ding, X., Tietze, J. K., & Hanke, T. (2007) · European Journal of Immunology · doi:10.1002/eji.200737126 · Cited by 81 · see citing works

IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming

Niu, N., Yao, J., Bast, R. C., Sood, A. K., & Liu, J. (2021) · Oncogenesis · doi:10.1038/s41389-021-00349-4 · Cited by 81 · see citing works

Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma

Alonso‐Nocelo, M., Ruíz-Cañas, L., Sancho, P., Görgülü, K., Alcalá, S., Pedrero, C., Vallespinós, M., López-Gil, J. C., Ochando, M., García-García, E., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325564 · Cited by 80 · see citing works

CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT

Noman, M. Z., Moer, K. V., Marani, V., Gemmill, R. M., Tranchevent, L.-C., Azuaje, F. J., Muller, A., Chouaı̈b, S., Thiery, J. P., Berchem, G., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1345415 · Cited by 79 · see citing works

Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment

García-Mendoza, M. G., Inman, D. R., Ponik, S. M., Jeffery, J. J., Sheerar, D. S., Doorn, R. R. V., & Keely, P. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0703-7 · Cited by 79 · see citing works

Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT

Zuo, J., Wen, J., Lei, M., Wen, M., Li, S., Lv, X., Luo, Z., & Wen, G. (2016) · Medical Oncology · doi:10.1007/s12032-015-0716-6 · Cited by 77 · see citing works

Tumor-Associated E-Cadherin Mutations Affect Binding to the Killer Cell Lectin-Like Receptor G1 in Humans

Schwartzkopff, S., Gründemann, C., Schweier, O., Rosshart, S. P., Karjalainen, K., Becker, K., & Pircher, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1022 · Cited by 76 · see citing works

Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution

Calvé, B. L., Griveau, A., Vindrieux, D., Maréchal, R., Wiel, C., Svrcek, M., Gout, J., Martin, L. A., Payen, L. F., Cros, J. F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8527 · Cited by 75 · see citing works

Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase

Park, H., Kim, K. M., Lee, H. C., Choi, H. N., Kim, D. J., Kim, B., & Moon, W. (2007) · Oncology Reports · doi:10.3892/or.18.6.1435 · Cited by 74 · see citing works

Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin.

Blaser, C., Kaufmann, M., & Pircher, H. (1998) · PubMed · Cited by 73 · see citing works

Cutting Edge: Virus-Activated CD8 T Cells and Lymphokine-Activated NK Cells Express the Mast Cell Function-Associated Antigen, An Inhibitory C-Type Lectin

Blaser, C., Kaufmann, M., & Pircher, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6451 · Cited by 71 · see citing works

Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancersPreprint

Takai, K., Drain, A. P., Lawson, D. A., Littlepage, L. E., Karpuj, M. V., Kessenbrock, K., Le, A. M., Inoue, K., Weaver, V. M., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.301366.117 · Cited by 69 · see citing works

The Fibronectin–ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells

Paavola, K. J., Roda, J. M., Lin, V. Y., Chen, P., O'Hollaren, K. P., Ventura, R., Crawley, S., Li, B., Chen, H.-I. H., Malmersjö, S., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0240 · Cited by 68 · see citing works

Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma

Peng, X., Li, L., Chen, J., Ren, Y., Liu, J., Yu, Z., Cao, H., & Chen, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01863 · Cited by 68 · see citing works

A Novel mTORC1/2 Inhibitor (MTI-31) Inhibits Tumor Growth, Epithelial–Mesenchymal Transition, Metastases, and Improves Antitumor Immunity in Preclinical Models of Lung Cancer

Zhang, Q., Zhang, Y., Chen, Y., Qian, J., Zhang, X., & Yu, K. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2548 · Cited by 65 · see citing works

A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer

Liu, J., Chiang, H.-C., Xiong, W., Laurent, V., Griffiths, S. C., Dülfer, J., Deng, H., Sun, X., Yin, Y. W., Li, W., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006720 · Cited by 65 · see citing works

Discoidin domain receptor 1 is a novel transcriptional target of ZEB 1 in breast epithelial cells undergoing H ‐ R as‐induced epithelial to mesenchymal transition

Koh, M., Woo, Y., Valiathan, R. R., Jung, H. Y., Park, S. Y., Kim, Y. N., Kim, H.-R. C., Fridman, R. A., & Moon, A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29154 · Cited by 63 · see citing works

Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer

Long, L., Hu, Y., Long, T., Lu, X., Tuo, Y., Li, Y., Wang, M., & Ke, Z. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003973 · Cited by 63 · see citing works

ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer

Liu, L., Tong, Q., Liu, S., Cui, J., Zhang, Q., Sun, W., & Yang, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148774 · Cited by 62 · see citing works

Vimentin: from a cytoskeletal protein to a critical modulator of immune response and a target for infection

Arrindell, J., & Desnues, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1224352 · Cited by 62 · see citing works

Oxidized LDL induces vimentin secretion by macrophages and contributes to atherosclerotic inflammation

Kim, S., Cho, W., Kim, I., Lee, S., Oh, G. T., & Park, Y. M. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01923-w · Cited by 59 · see citing works

Extracellular vimentin modulates human dendritic cell activation

Yu, M. B., Guerra, J., Firek, A. F., & Langridge, W. H. R. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.017 · Cited by 59 · see citing works

DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition

Xie, R., Wang, X., Qi, G., Wu, Z., Wei, R., Li, P., & Zhang, D. (2016) · Tumor Biology · doi:10.1007/s13277-016-5070-6 · Cited by 54 · see citing works

TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking

Ezzoukhry, Z., Henriet, E., Piquet, L., Boyé, K., Bioulac‐Sage, P., Balabaud, C. P., Couchy, G., Zucman‐Rossi, J., Moreau, V., & Saltel, F. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.09.003 · Cited by 54 · see citing works

Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454–3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC

Xia, Y., Wang, W., Shen, W., Xu, K., Hu, Y., Han, G., & Liu, Y.-B. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109652 · Cited by 53 · see citing works

miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer

Xi, Q., Chen, Y., Yang, G.-Z., Zhang, J., Zhang, L., Guo, X.-D., Zhao, J., Xue, Z., Yan, L., & Zhang, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00890 · Cited by 50 · see citing works

Epithelial to mesenchymal transition influences fibroblast phenotype in colorectal cancer by altering miR‐200 levels in extracellular vesicles

Bhome, R., Emaduddin, M., James, V. H., House, L. M., Thirdborough, S. M., Mellone, M., Tulkens, J., Primrose, J. N., Thomas, G. J., Wever, O. D., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12226 · Cited by 50 · see citing works

Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer

Liang, Y., Liu, Y., Zhang, Q., Zhang, H., & Du, J. (2020) · Translational research · doi:10.1016/j.trsl.2020.12.003 · Cited by 47 · see citing works

Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer

Sample, R. A., Nogueira, M. F., Mitra, R. D., & Puram, S. V. (2023) · Oncogene · doi:10.1038/s41388-023-02749-9 · Cited by 47 · see citing works

Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance

Tabatabaee, A., Nafari, B., Farhang, A., Hariri, A., Khosravi, A., Zarrabi, A., & Mirian, M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10154-7 · Cited by 47 · see citing works

Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer

Gu, A., Jie, Y., Yao, Q., Zhang, Y., & Mingyan, E. (2016) · Reproductive Sciences · doi:10.1177/1933719116654989 · Cited by 46 · see citing works

Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma

Ueno, T., Tsuchikawa, T., Hatanaka, K. C., Hatanaka, Y., Mitsuhashi, T., Nakanishi, Y., Noji, T., Nakamura, T., Okamura, K., Matsuno, Y., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25050 · Cited by 46 · see citing works

BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer

Rouanne, M., Adam, J., Radulescu, C., Letourneur, D., Bredel, D., Mouraud, S., Goubet, A.-G., Leduc, M., Chen, N., Tan, T. Z., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci145666 · Cited by 43 · see citing works

The Yin and Yang of Targeting KLRG1+ Tregs and Effector Cells

Borys, S. M., Bag, A. K., Brossay, L., & Adeegbe, D. O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.894508 · Cited by 42 · see citing works

T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?

French, J., Cresswell, J., Wong, W. K., Seymour, K., Charnley, R., & Kirby, J. A. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600597 · Cited by 42 · see citing works

Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer

Ippolito, L., Duatti, A., Iozzo, M., Comito, G., Pardella, E., Lorito, N., Bacci, M., Pranzini, E., Santi, A., Sandrini, G., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00180-z · Cited by 41 · see citing works

Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells

Song, J., Chen, X., Bai, J., Liu, Q., Li, H., Xie, J., Jing, H., & Zheng, J. (2016) · Tumor Biology · doi:10.1007/s13277-016-5021-2 · Cited by 40 · see citing works

PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers

Wu, T., Tang, C., Tao, R.-C., Yong, X., Jiang, Q.-Z., & Feng, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693881 · Cited by 38 · see citing works

Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockade

Mei, J., Cai, Y., Xu, R., Li, Q., Chu, J., Luo, Z., Sun, Y., Shi, Y., Xu, J., Li, D., et al. (2024) · 癌症：英文版 · doi:10.1002/cac2.12538 · Cited by 37 · see citing works

PD-L1 Induces Epithelial‐Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway

Fei, Z., Deng, Z., Zhou, L., Li, K., Xia, X., & Xie, R. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15446984186056 · Cited by 36 · see citing works

Lactic acid in macrophage polarization: A factor in carcinogenesis and a promising target for cancer therapy

Ajam-Hosseini, M., Heydari, R., Rasouli, M., Akhoondi, F., Hanjani, N. A., Bekeschus, S., & Doroudian, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116098 · Cited by 34 · see citing works

Immune checkpoint molecules are regulated by transforming growth factor (TGF)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma

Shrestha, R., Bridle, K. R., Crawford, D. H., & Jayachandran, A. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.54239 · Cited by 28 · see citing works

Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells

Gu, Y., Zhang, Z., Camps, M. G. M., OSSENDORP, F. A., Wijdeven, R. H. M., & ten Dijke, P. (2023) · Science Advances · doi:10.1126/sciadv.adf9915 · Cited by 23 · see citing works

Biochanin A Suppresses Tumor Progression and PD-L1 Expression via Inhibiting ZEB1 Expression in Colorectal Cancer

Xu, J., Yang, X., Pan, J., Fan, H., Mei, J., & Hua, D. (2022) · Journal of Oncology · doi:10.1155/2022/3224373 · Cited by 22 · see citing works

LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets

Xiang, Z., Yin, X., Wei, L., Peng, M., Zhu, Q. K., Lu, X., Guo, J., Zhang, J., Li, X., & Zou, Y. (2024) · Biomolecules · doi:10.3390/biom14020187 · Cited by 21 · see citing works

Epithelial–mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population

Collino, F., Revelli, A., Massobrio, M., Katsaros, D., Schmitt-Ney, M., Camussi, G., & Bussolati, B. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.06.010 · Cited by 20 · see citing works

Immunoregulatory influence of abundant MFG ‐E8 expression by esophageal cancer treated with chemotherapy

Kanemura, T., Miyata, H., Makino, T., Tanaka, K., Sugimura, K., Hamada‐Uematsu, M., Mizote, Y., Uchida, H., Miyazaki, Y., Takahashi, T., et al. (2018) · Cancer Science · doi:10.1111/cas.13785 · Cited by 18 · see citing works

Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoint ILT3/LILRB4/gp49B

Itagaki, F., Nakatsuka, K., Sakai, H., Endo, S., Su, M., & Takai, T. (2023) · International Immunology · doi:10.1093/intimm/dxad012 · Cited by 17 · see citing works

SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC

Hasmim, M., Xiao, M., Moer, K. V., Kumar, A., Oniga, A., Mittelbronn, M. G. A., Duhem, C., Chammout, A., Berchem, G., Thiery, J. P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982821 · Cited by 15 · see citing works

Immunoproteasome acted as immunotherapy ‘coffee companion’ in advanced carcinoma therapy

Shi, S., Ou, X., Liu, C., Wen, H., & Jiang, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1464267 · Cited by 6 · see citing works

Metabolic Rewiring Is Required for Epithelial–Mesenchymal Transition

(2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2014-190 · Cited by 1 · see citing works

Short peptides sensitize target cells to CTL specific for the MHC class Ib molecule, H2-M3

Dabhi, V. M., & Fischer Lindahl, K. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11

Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis

Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 66 · see citing works

Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches

Bakrim, S., Fessikh, M. E., Elhrech, H., Omari, N. E., Amanullah, M. R., Ming, L. C., Moshawih, S., & Bouyahya, A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06583-3 · Cited by 52 · see citing works

Cancer Metastasis: Therapeutic Challenges and Opportunities

Garemilla, S. S. S., Kadambala, M. C., Gampa, S. C., Chinthala, S., & Garimella, S. V. (2025) · Medical Oncology · doi:10.1007/s12032-025-03072-x · Cited by 13 · see citing works

Pathological extranodal extension in head and neck cancer: A prognostic biomarker with therapeutic ramifications and diagnostic pitfalls

Chohan, S., & Zaheer, S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156183 · Cited by 9 · see citing works

Molecular landscape of colorectal cancer liver metastasis: Tumor microenvironment heterogeneity and driver inference

Zhang, A., Zhang, Y., Xu, J., Zhu, R., Liang, T., & Guo, L. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104946 · Cited by 8 · see citing works

Hsp60-Bearing Exosomes in Helicobacter pylori-Induced Gastric Tumorigenesis: A Pathomorphological and Therapeutical Overview

Gratie, M. I., Manna, O. M., Accomando, S., Tomasello, G., Cappello, F., & Fucarino, A. (2025) · Cells · doi:10.3390/cells14211652 · Cited by 8 · see citing works

EMT: from embryogenesis, through cancer progression, to the development of carcinosarcoma

Guarino, M. (2025) · Differentiation · doi:10.1016/j.diff.2025.100903 · Cited by 7 · see citing works

Understanding the Cancer-Associated Fibroblast (CAF) and Its Biomarker Fibroblast Activation Protein (FAP), and Aspects in Human Liver Cancer

Qu, Y. A., Huang, J. C. N., Wang, Z. V., Ferguson, A. L., Nguyen, J. M. H. N., Zhang, M. N., Osborne, K., Boumelhem, B. B., McCaughan, G. W., Liu, K., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl44837 · Cited by 7 · see citing works

The critical role of epithelial-mesenchymal transition (EMT) in colorectal cancer progression and therapeutic outcomes

Jiang, H., & Xu, B. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105189 · Cited by 6 · see citing works

Multi-Omic Characterization of Epithelial–Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma

Bertoldi, A., Cusumano, G., Calzoni, E., Alabed, H. B. R., Pellegrino, R. M., Buratta, S., Urbanelli, L., & Emiliani, C. (2025) · Cells · doi:10.3390/cells14161233 · Cited by 5 · see citing works

Cell-free RNA profiling uncovers non-canonical circulating D2 transcript elevation in Bladder Cancer plasma

Nappi, A., Crocetto, F., Conforti, P., Sagliocchi, S., Cicatiello, A. G., Restolfer, F., Acampora, L., Mastro, S. D., Sirica, R., Spirito, L., et al. (2026) · The Journal of Liquid Biopsy · doi:10.1016/j.jlb.2025.100454 · Cited by 5 · see citing works

Anticancer Activity of Jania rubens in HCT-116 Cells via EMT Suppression, TET Downregulation, and ROS-Mediated Cytotoxicity

Radwan, Z., Kassir, R., Feghali, F. A., Zaiter, R., Daher, M. A., Roufayel, R., Fajloun, Z., Mawlawi, H., El-Sabban, M. E., & Dassouki, Z. (2025) · Biomolecules · doi:10.3390/biom15101361 · Cited by 4 · see citing works

Hallmarks of epithelial-mesenchymal plasticity in cancer

Clauzon, L., Verona, F., Shams, K., Brancato, O. R., Bella, S. D., di Miceli, N., Stassi, G., & Franco, S. D. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02690-x · Cited by 4 · see citing works

The exosomal miRNA-3184-3p derived from highly metastatic melanoma cells promotes metastatic competency via the positive feedback loop of NLK/Wnt/S100A11

Chen, Y., Zeng, B., Xiang, M., Han, X. T., Zhang, X., Chen, H. H., Zhao, Q., Liu, D., Li, X., Li, J., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117086 · Cited by 4 · see citing works

The Potential Mechanisms of Ochratoxin A in Prostate Cancer Development: An Integrated Study Combining Network Toxicology, Machine Learning, and Molecular Docking

Cai, H., Shen, D., Hu, X., Yin, H., & Yan, Z. (2025) · Toxins · doi:10.3390/toxins17080388 · Cited by 4 · see citing works

Prognostic role and functional impact of cadherin genes in non-small cell lung cancer tumorigenesis: mechanistic insights from in silico and in vitro analyses

Yang, Q., Feng, N., Shen, F., Bai, L., Li, R., Li, S., & Zhang, W. (2025) · PeerJ · doi:10.7717/peerj.19785 · Cited by 3 · see citing works

Cytoskeletal dynamics in breast cancer: mechanistic insights and therapeutic opportunities

Malla, R. R., Tumbali, A., Chode, P., Manda, K., Samudrala, A. S., Nuthalapati, Y., Mangam, C., Bhamidipati, P., Srilatha, M., & Nagaraju, G. P. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2025.09.006 · Cited by 3 · see citing works

USP20 competitively binds to STUB1 to enhance CTSL expression and promote epithelial‐mesenchymal transition in head and neck squamous cell carcinoma

Guo, L., Zhang, B., Cui, X., Wang, X., Xiao, J., Miao, S., Song, K., & Sun, J. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70520 · Cited by 3 · see citing works

Cellular signaling and radioresistance in prostate cancer

Sosa, G. A., Crosswhite, B., & Kirschner, A. N. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112367 · Cited by 3 · see citing works

The spatiotemporal dynamics of epithelial-mesenchymal transition (EMT): Coordinating the tumor microenvironment to promote the metastatic cascade

Jin, L., Wang, Y., Mao, S., Yao, Y., Yang, X., & Qian, J. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100185 · Cited by 3 · see citing works

Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor‐adapted non‐small cell lung cancer cell lines

Nanthaprakash, T. V., Gourlay, C. W., Oehme, I., Garrett, M. D., Cínatl, J., Wass, M. N., & Michaelis, M. (2025) · FEBS Open Bio · doi:10.1002/2211-5463.70076 · Cited by 2 · see citing works

Cedrol impedes lung cancer metastasis by reducing tumor-associated macrophage polarization mediated by MYC-driven aerobic glycolysis

Li, Q., Liu, Y., Zhang, L., Zheng, Y., Feng, X., & Wang, Y. (2025) · Human Cell · doi:10.1007/s13577-025-01299-4 · Cited by 2 · see citing works

Yin Yang 1 activates JAK-STAT3-mediated epithelial-mesenchymal transition in Helicobacter pylori -induced gastric cancer progression

Chen, J.-W., Ouyang, J.-J., Wang, Z., Ma, D.-M., Zhang, Z., Teng, Q., Yu, G., & Li, X. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i12.112626 · Cited by 2 · see citing works

Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

Al‐Khreisat, M. J., Abdulsahib, W. K., Jasim, I. K., Malathi, H., Nayak, P. P., Anand, D. A., Mukherjee, G., Sinha, A., & Kholboyev, N. (2026) · Discover Oncology · doi:10.1007/s12672-026-04731-9 · Cited by 2 · see citing works

Natural Modulators of Aquaporins in Cancer Therapy: Functional Mechanisms and Clinical Potential

Małkowska, P., & Tarnowski, M. (2026) · Molecules · doi:10.3390/molecules31071072 · Cited by 2 · see citing works

Integrating Tumor Budding and the Invasive-Front Microenvironment in Colorectal Carcinoma: An Exploratory Histopathological Score-Based Association Study

Zuccalà, V., Fiorentino, V., Martorana, T. M., Ricciardi, G., Tralongo, P., Ciappina, G., Abbonante, V., Ammendola, M., Berretta, M., Fadda, G., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114971 · Cited by 2 · see citing works

Mechanobiology of solid tumor vasculature: implications for tumor progression

Kondapaneni, R. V., Libring, S., Dsa, S., & Reinhart‐King, C. A. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10345-y · Cited by 2 · see citing works

UBE2T promotes epithelial‑mesenchymal transition and motility in oral cancer cells via induction of IL‑6 expression

Watanabe, A., Jin, L., Ishihara, K., Iwabuchi, S., Ohno, K., Hashimoto, S., Asakage, T., Takahashi, K., Podyma‐Inoue, K. A., & Watabe, T. (2025) · Oncology Letters · doi:10.3892/ol.2025.15219 · Cited by 2 · see citing works

ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD‐Mediated EMT Signaling Pathway

Ding, J., Shen, H., Ji, J., Li, J., Shi, Z., Wang, X., Li, B., Hou, Y., Min, W., Sun, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202506718 · Cited by 1 · see citing works

Comprehensive Computational Assessment of SNAI1 and SNAI2 in Gastric Cancer: Linking EMT, Tumor Microenvironment, and Survival Outcomes

Kalantari-Dehaghi, M., Rahimi-Tamandegani, H., & Emadi‐Baygi, M. (2025) · Cancer Informatics · doi:10.1177/11769351251352892 · Cited by 1 · see citing works

Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition

Thakur, K. K., Harsha, C., Sailo, B. L., Chinnathambi, A., Alharbi, S. A., Hegde, M., Monisha, J., Ma, Z., & Kunnumakkara, A. B. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04081-y · Cited by 1 · see citing works

Therapeutic Synergy of Silibinin‐Loaded Nanogel and Low‐Dose Gamma Radiation in Hepatocellular Carcinoma: Emphasis on EMT, Angiogenesis, and Immune Response

Alghzzawy, Z. M., Awwad, M. H., Elmaghraby, T. K., Hagag, S. A. E.-H., Kayed, A. E., & Ibrahim, D. S. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500453 · Cited by 1 · see citing works

Intelligent design of tumor microenvironment-responsive Adeno-associated virus vectors: overcoming delivery barriers and enabling precision therapy

Wu, Z., Liu, H., & Wu, D. (2025) · Medical Oncology · doi:10.1007/s12032-025-03158-6 · Cited by 1 · see citing works

IL-6 Promoter Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis of 16,499 Cases and 21,186 Controls

Negahi, A., Negahban, H., Sayad, S., Khosravi-Mashizi, M., Alijanpour, A., Rahmani, A., Shahbazi, A., Jayervand, F., Dastgheib, S. A., Yeganegi, M., et al. (2026) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-025-02517-z · Cited by 1 · see citing works

MiR-200c restoration inhibits FOXP3 and metastatic spread in breast cancer: evidence from in vitro and in vivo models

El-Khazragy, N. N., Alsolami, A. A., Aref, A. M., Hassan, M. N. M., & Othman, M. S. (2026) · BMC Cancer · doi:10.1186/s12885-026-15574-6 · Cited by 1 · see citing works

Epithelial-mesenchymal transition and sunitinib resistance in renal cell carcinoma: mechanisms and therapeutic strategies

Zhang, M., Zhang, Y., Shen, F., Yan, M., Cheng, P., Teng, J., Zou, M., Yao, W., Wang, Z., & Li, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1761280 · Cited by 1 · see citing works

Extracellular Vesicles from Capparis spinosa Modulate Epithelial-to-Mesenchymal Transition in Huh7 Hepatocellular Carcinoma Cells

Bertoldi, A., Calzoni, E., Cusumano, G., Alabed, H. B. R., Pellegrino, R. M., Emiliani, C., & Urbanelli, L. (2026) · Nanomaterials · doi:10.3390/nano16070394 · Cited by 1 · see citing works

Endometriosis and Endometrial Cancer—Association Between Biological Mechanisms and Its Clinical Implications

Marczuk, K. M., Mamala, M. B., Szuster, E., & Murawski, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15082891 · Cited by 1 · see citing works

Perioperative local anesthetics as modulators of tumor progression and metastasis

Zheng, X., & Wei, H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1793731 · Cited by 1 · see citing works

The application of federated learning in breast cancer diagnosis and treatment: a survey

Wu, H., & Ghorbian, M. (2026) · Artificial Intelligence Review · doi:10.1007/s10462-026-11574-x · Cited by 1 · see citing works

BFO@Au leveraged membrane necrotherapy: Rapid tumor eradication via membrane oxidation and immune activation

Wang, Z., Zhang, F., Bingshuai, 周. Z., Cui, Y., Sun, L., Won, M., Xu, L., Sun, J., Wang, L., Kim, J. S., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124299 · Cited by 1 · see citing works

Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer

Yadav, B., Kollur, S. P., Ali, A., Arora, P., Gupta, A., Saranraj, P., Upadhye, V. J., & Singh, P. (2026) · Discover Oncology · doi:10.1007/s12672-026-05130-w · Cited by 1 · see citing works

Venom-Derived Enzyme Inhibitors as Anticancer Agents: Structure–Activity Relationships, Molecular Targets and Mechanistic Insights

Ogundele, A. V., Nongthombam, G. S., Nwagu, A. D., Silva, H. H., & Fabiyi, O. A. (2026) · Molecules · doi:10.3390/molecules31132398 · Cited by 1 · see citing works

SHADE: A Multilevel Bayesian Approach to Modeling Directional Spatial Associations in TissuesPreprint

Eliason, J., Peruzzi, M., & Rao, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.24.661393

Advances in application of single-cell sequencing in colorectal cancer

Gong, T., & Liu, Y.-K. (2025) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v33.i10.771

Tumor microenvironment-derived IL-32 promotes aggressive phenotypes and stem cell traits in head and neck squamous cell carcinoma

Liu, N.-T., Yang, S. D., Chang, Y., Yu, J.-H., Chen, S.-F., Lin, Y.-S., & Lin, Y.-C. (2025) · Journal of Dental Sciences · doi:10.1016/j.jds.2025.10.010

PPP1R3G Orchestrates Tumor-Immune Crosstalk and Drives Therapeutic Vulnerability in Lung Adenocarcinoma: A Multi-Omics Exploration of Prognostic, Mechanistic, and Immunotherapeutic InsightsPreprint

Li, X., Fu, X., Dai, X., Sun, H., Wang, M., Deng, Y., Zhang, H., & Lin, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-8127673/v1

Targeting epithelial-to-mesenchymal transition of cancer cells by sulfated glycans from marine algae

Malyarenko, O. S., Kravchenko, A. O., Druzhinina, V. R., Gundamaraju, R., Ermakova, S. P., & Ambati, R. R. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100172

IMMUNOFLUORESCENT ASSESSMENT OF VIMENTIN DE NOVO EXPRESSION IN SEROUS OVARIAN CANCER CELLS AS A POTENTIAL PREDICTOR OF PLATINUM AND TAXANE DRUGS EFFICACY

Богуш, Т. А., Grishanina, A. N., Богуш, Е. А., Scherbakov, A. M., Ogurechnikova, E. A., Равчеева, А. Б., Kapura-Brekhovskikh, E. M., & Melnikov, M. Y. (2025) · Lomonosov chemistry journal · doi:10.55959/msu0579-9384-2-2026-67-1-35-42

Uncovering EMT-Associated Molecular Mechanisms Through Integrative Transcriptomic and Machine Learning Analyses

Büyükkılıç, Ş., Alotaibi, H., Georgakilas, A. G., & Pavlopoulou, A. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl48085

Authors’ Response to Peer Reviews of “Localized Immune Cascade Programming in Desmoplastic Tumors: In Silico Modeling and Validation Study”

Novruzov, M., Mammadova, M., Raval, K. Y., Khan, W. U., & Shiraliyeva, U. (2026) · JMIRx Bio · doi:10.2196/91528

Immunofluorescence Assay of De Novo Vimentin Expression in Serous Ovarian Cancer Cells as a Potential Predictor of the Efficacy of Platinum-Based Drugs and Taxanes

Богуш, Т. А., Grishanina, A. N., Bogush, E. A., Scherbakov, A. M., Ogurechnikova, E. A., Равчеева, А. Б., Kapura-Brekhovskikh, E. M., & Melnikov, M. Y. (2026) · Moscow University Chemistry Bulletin · doi:10.3103/s0027131425700476

Engineering Bone-Mimetic Microspheres to Recapitulate the Tumor Microenvironment for In Vitro Osteosarcoma Modeling

Zheng, F., Lan, Z., Chen, H., & Ma, M. (2026) · Biomedicines · doi:10.3390/biomedicines14040868

Dissecting molecular heterogeneity in primary gastric cancer by IGFBP7-related analysis

Liu, Y.-J., Ye, Q., Zhang, W., Li, J.-P., Ji, L.-P., Liu, S.-L., & Zou, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08110-4

Predicting muscle-invasive bladder cancer with dual-layer detector spectral CT-derived extracellular volume fraction

Lv, J., Yang, P., Zheng, W., Huang, D., Feng, Y., Huang, B., Mu, R., Dai, S., Li, P., Yang, P., et al. (2026) · BMC Medical Imaging · doi:10.1186/s12880-026-02342-y

Hemozoin-induced immunomodulation and prostate carcinogenesis: mechanisms and implications

Akinyosoye, A. D., Rotimi, S. O., Olasehinde, O. E., Oduselu, G. O., Oranusi, S. U., & Akinnola, O. O. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1786079

Precisely Controllable Y‐Shaped DNA Nanomachine‐Immunoassay System: Noninvasive Monitoring of Tumor Progression and Metastasis

Jiang, P., Fan, Z., Wang, Y., Li, J., Kang, X., Feng, L. L., & Chen, P. (2026) · Advanced Functional Materials · doi:10.1002/adfm.75631

Résistance à l’immunothérapie dans le CBNPC : état des connaissances actuelles

Ancel, J., Dewolf, M., Nawrocki‐Raby, B., Durlach, A., Dalstein, V., Cortot, A. B., Dormoy, V., Gilles, C., Polette, M., & Deslée, G. (2026) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2026.04.002

Molecular Functions and Drug Prediction of MMP1 and TGFBR2 in Nasopharyngeal Carcinoma

Wang, F., Ge, B., Li, M., Xia, X., Zhang, F., & Xu, P. (2026) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.70222

Pathogenetic features of sarcomatoid carcinoma

Freynd, G. G., & Chub, I. S. (2026) · Perm Medical Journal · doi:10.17816/pmj4325-14

Cross-Cancer Profiling of Cadherin-1 Reveals Context-Dependent Epithelial–Mesenchymal Transition Decoupling, Immune Heterogeneity, and Prognostic Variability in Epithelial CancersPreprint

Rahman, M. A., Bellah, S. F., & Rahman, M. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727338

Integrated Single-Cell Virtual Knockout and Machine Learning Analyses Reveal a Protective Role of CKAP2 in Gastric Cancer

Yang, J., Qiu, Z., Song, W., Liu, X., Ouyang, T., Shu, J., Wang, J., & Yang, Y. (2026) · Molecules · doi:10.3390/molecules31111901

Genome Organizer SATB1 selectively activates a defined subset of EMT genes driving metastatic breast cancerPreprint

Kohwi, Y., Vayn, Y., Grange, M., Ho, B., Heditsian, D. M., & Kohwi-shigematsu, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.29.728584

Ex Vivo Culture of Patient-Derived Primary, Metastatic, and Post-Mortem Lung Cancer Reveals Targetable States of EMT and Metabolic PlasticityPreprint

Acevedo‐Acevedo, S., Ackerman, H. D., Rubio, V. Y., Hackel, N. R., Carr, C. L., Miranda, K., Baldwin, J. R., Reiser, M. A., Lockhart, J. H., Lui, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.14.731898

A Unified Taxonomy for the Circulating Tumor Microenvironment (cTME) and Circulating Tumor-Associated Cells (C-TACs): A Conceptual Framework for Precision Oncology

Sawabata, N. (2026) · Cells · doi:10.3390/cells15121108

Dihydrocapsaicin suppresses the migration and invasion of gastric cancer cells by upregulating TRPV1 expression

Fu, Y., Wang, Y., Cai, Z., Huang, S., & Chen, J. (2026) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-026-01226-3

H. pylori infection amplifies oncogenic functions of CXCL8, CXCL1, CCL20, and MMP1 in gastric cancer: Evidence from network biology and functional assays

Sima, J., Ren, X., Chen, Y., Fan, J., Li, X., Li, K., Yang, Q., & Xie, Y. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108746

TFAP4-DPEP1 Regulatory Axis Promotes Malignant Progression by Inducing EMT and Cancer Stemness in Colorectal CancerPreprint

Chen, D., Zhou, M., Xu, H., Li, R., Quanhong, X., & Sun, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-9474770/v1

Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects

Meftahpour, V., Dakal, T. C., Maciaczyk, J., Sharma, A., & Schmidt‐Wolf, I. G. H. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02881-4

Toxicity and Safety Assessment of Heterocyclic Anticancer Agents

Kesharwani, G., Mishra, A., Mishra, P., & Dewangan, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898817084126010012

Postoperative wound microenvironment regulates breast cancer stem cell fate and clinical implications

Yang, C., Wen, Z., Huang, X., Yang, Y., Zhang, J., Li, Y., Wang, Y., & Zhong, Y. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12620-1

Chaperone-mediated autophagy as a regulator of hallmarks of cancer

Tiwari, M., Sharma, L. K., Chakravarti, B., Singh, V. K., Singh, S., & Shrivastava, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1927298

Hope is linked with more favorable tumor molecular signatures in serous ovarian cancer

Lutgendorf, S. K., Corn, B. W., Thaker, P. H., Goodheart, M. J., Penedo, F. J., Sood, A. K., & Cole, S. W. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107001

From virtual screening to cell-based assays: structure-guided identification of EGFR-targeting perimidine derivatives with anticancer activity

Gopinadh, M., Sreehari, A. P., Sunish, K. S., Ashif, M., Sivan, U., & Daniel, S. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05836-2

Human Papillomavirus (HPV) Infection-Associated Epithelial-to-Mesenchymal Transition: Implication in Tumorigenesis and Pathogenesis of HPV-Positive Cancers

Kabakov, A. E., Николаевна, М. О., Khokhlova, A. V., & Kaprin, A. D. (2026) · Cells · doi:10.3390/cells15201916

Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy

Khan, M. M. U., Khan, M. A., Azam, M., Afzal, M., & Alsahli, T. G. (2026) · Cells · doi:10.3390/cells15191812

EML4–ALK fusion rewires transcriptomic, miRNA, and CAF-associated programs in non-small cell lung cancer

Mishra, D., Agrawal, S., Malik, D., Pathak, E., & Mishra, R. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04569-1

Flavonoids in cancer pharmacology: molecular mechanisms, tumor microenvironment regulation, and drug resistance

Yu, Z., Zhou, Z., Yin, N., & Ge, H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1969337

Quercetin in oral squamous cell carcinoma: Integrating immunometabolic reprogramming, cancer stem cell plasticity, and precision therapeutic strategies

Das, R., Yadav, S., Das, S., & Prajapati, S. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156710

MHC-I downregulation is associated with immune-evasion in breast cancers with heterogeneous activation of epithelial-mesenchymal plasticityPreprint

Bakhle, K. M., Stephanou, A., Sahoo, S., Ntekas, I., Priebe, K., Rahman, M., Puri, R., Butler, S. D., Schweitzer, P. A., Chandraganti, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.17.759751

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

Glaviano, A., Lau, H., Carter, L. M., Lee, E. H. C., Lam, H. Y., Okina, E., Tan, D. J. J., Tan, W., Ang, H. L., Carbone, D., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01634-6 · Cited by 162 · see citing works

The spatiotemporal dynamics of epithelial-mesenchymal transition (EMT): Coordinating the tumor microenvironment to promote the metastatic cascade

Jin, L., Wang, Y., Mao, S., Yao, Y., Yang, X., & Qian, J. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100185 · Cited by 3 · see citing works

Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics

Zhang, J., Hu, Z., Horta, C. A., & Yang, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.002 · Cited by 103 · see citing works

Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment

D'Angelo, E., Lindoso, R. S., Sensi, F., Pucciarelli, S., Bussolati, B., Agostini, M., & Collino, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01122 · Cited by 25 · see citing works

Mechanism of tumor microenvironment and epithelial-mesenchymal transition

Lai-ku, L. (2010) · International Journal of Stomatology